Surgical Drapes and Gowns Market - Global Forecast To 2030
商品番号 : SMB-91942
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年12月 |
| ページ数 | 379 |
| 図表数 | 492 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
手術用ガウンとドレープ市場 – 製品タイプ（ドレープ、ガウン）、用途（使い捨て、再利用可能）、材質[不織布（PP、PE）、織物（綿、ポリエステル）]、滅菌性、用途（心臓血管、腹腔鏡検査、エンドユーザー（病院、ASC） – 2030年までの世界予測
世界の手術用ガウンおよびドレープ市場は、2025年の46億9,000万米ドルから2030年には60億1,000万米ドルに達し、予測期間中に5.1%の年平均成長率（CAGR）で成長すると予測されています。医療関連感染症（HAI）の蔓延、外科手術の増加、そして繊維技術の進歩により、市場は高い成長を遂げると見込まれています。感染予防と患者の安全への関心の高まり、そして抗菌性および耐液性素材の革新は、高品質の手術用ガウンおよびドレープの需要を促進しています。しかしながら、使い捨て製品の環境への影響や高級手術用繊維の高コストに対する懸念が、市場の成長を抑制する可能性があります。とはいえ、製品性能の継続的な向上と、病院や医療施設での採用増加が、市場拡大の原動力となると予想されます。
調査範囲
本レポートは、手術用ガウンおよびドレープ市場を、製品タイプ、素材、滅菌性、用途、エンドユーザー、地域の観点から分析しています。また、市場の成長に影響を与える主要要因（促進要因、抑制要因、機会、課題など）を分析するとともに、市場リーダー企業の競争環境について詳細な分析を提供しています。さらに、ミクロ市場を個々の成長傾向の観点から分析しています。さらに、5つの主要地域（および各地域に所在する国）における市場セグメントの収益予測も提供しています。
レポートを購入する理由
本レポートは、既存企業だけでなく、新規参入企業も市場の動向を把握し、より大きな市場シェアを獲得することを可能にします。本レポートを購入する企業は、以下に示す戦略を1つ以上活用することで、市場でのプレゼンスを強化できます。
本レポートでは、以下の点について洞察を提供します。
- 主要な推進要因（院内感染（HAI）の有病率増加、外科手術件数の増加、感染予防プロトコルへの関心の高まり、外来手術センターの拡大）の分析、制約要因（発展途上地域における手術用ガウンおよびドレープの再利用、高級使い捨て製品の高コスト）、機会（新興国における成長機会、先進的な繊維技術の導入）、課題（原材料のサプライチェーンにおける変動性、低コストサプライヤー間の品質のばらつき）
- 市場浸透：手術用ガウンおよびドレープ市場における主要企業が提供する製品ポートフォリオに関する包括的な情報
- 製品開発／イノベーション：手術用ガウンおよびドレープ市場における今後のトレンド、研究開発活動、新製品発売に関する詳細な洞察
- 市場開発：収益性の高い新興地域に関する包括的な情報
- 市場多様化：手術用ガウンおよびドレープ市場における新製品、成長地域、最近の動向に関する包括的な情報
- 競合評価：Cardinal Health（米国）、Owens & Minor（米国）、Medline Industries, LP.（米国）、McKesson Corporation（米国）、Mölnlycke AB（スウェーデン）など、主要市場企業の市場セグメント、成長戦略、収益分析、製品に関する詳細な評価
The global surgical gowns and drapes market is projected to reach USD 6.01 billion by 2030 from USD 4.69 billion in 2025, at a CAGR of 5.1% during the forecast period. The market is expected to experience high growth due to the rising prevalence of healthcare-associated infections (HAIs), an increase in surgical procedures, and advancements in fabric technologies. The growing focus on infection prevention and patient safety, as well as innovations in antimicrobial and fluid-resistant materials, are driving the demand for high-quality surgical gowns and drapes. However, concerns over the environmental impact of disposable products and the high cost of premium surgical textiles may restrain market growth. Nonetheless, the continuous improvement in product performance and increasing adoption in hospitals and healthcare facilities are expected to fuel the market expansion.
The hospitals segment is expected to have the largest market during the forecast period.
Based on end user, the market is segmented into hospitals, ambulatory surgical centers, and other end users. In 2024, hospitals accounted for the largest share of the market. The hospital segment is the largest in the surgical gowns and drapes market due to the high volume of surgeries and medical procedures performed in hospitals worldwide. Hospitals are primary settings for surgeries, where maintaining a sterile environment is critical to preventing infections and ensuring patient safety. The demand for surgical gowns and drapes in hospitals is driven by the need for high-quality, reliable infection control products to protect both patients and healthcare professionals. Additionally, hospitals are more likely to adopt advanced materials and technologies, such as fluid-resistant and antimicrobial fabrics, to enhance infection prevention. With a constant need for surgical gowns and drapes in operating rooms, patient care areas, and other clinical settings, the hospital segment remains the largest and most dominant end user in the market.
The general surgery products segment accounted for the largest market share in the surgical gowns and drapes market.
The surgical gowns and drapes market is segmented into general surgery, cardiovascular, gynecology, ophthalmology, lithotomy & laparoscopy, and other applications, based on application. The general surgery segment is the largest in the surgical gowns and drapes market due to the high volume of procedures performed globally. General surgeries, such as appendectomies, gallbladder removals, and hernia repairs, are among the most common medical procedures, driving significant demand for surgical gowns and drapes. These surgeries require strict infection control measures to ensure patient safety, making high-quality surgical textiles essential. The widespread use of disposable gowns and drapes in general surgery helps maintain a sterile environment, reduce the risk of infections, and enhance overall procedural efficiency. As general surgeries continue to be performed at a high rate, this segment remains the dominant driver of growth in the surgical gowns and drapes market.
Asia Pacific is expected to be the fastest-growing market for surgical gowns and drapes during the forecast period.
The global surgical gowns and drapes market is segmented into six segments, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific is expected to be the fastest-growing market for surgical gowns and drapes during the forecast period. The region’s rapid urbanization, coupled with growing healthcare infrastructure, has significantly increased the demand for infection control products, including surgical gowns and drapes. As the number of surgeries rises in countries like China, India, and Southeast Asia, the need for high-quality, cost-effective surgical textiles grows. Moreover, the increasing prevalence of healthcare-associated infections (HAIs) and government initiatives aimed at improving healthcare standards are further driving the adoption of surgical gowns and drapes in the region. With a large population base and a growing focus on patient safety, the Asia Pacific is poised to experience substantial growth in this market over the coming years.
North America leads the surgical gowns and drapes market in terms of market size, driven by its advanced healthcare systems and high number of surgical procedures performed annually. The region’s well-established healthcare infrastructure, coupled with stringent infection control regulations, has made surgical gowns and drapes essential in maintaining sterile environments during surgeries. Additionally, North America’s focus on patient safety and the adoption of advanced fabric technologies, such as antimicrobial and fluid-resistant materials, further boost the demand for these products. The presence of leading manufacturers and significant healthcare expenditure in countries such as the US and Canada ensures that North America remains the dominant market for surgical gowns and drapes.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1: 28%, Tier 2: 42%, and Tier 3: 30%
- By Designation: C Level: 30%, Director Level: 34%, and Others: 36%
- By Region: North America: 51%, Europe: 21%, Asia Pacific: 18%, Latin America: 6%, and Middle East & Africa: 4%
- Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The major players operating in the surgical gowns and drapes market are Cardinal Health (US), Owens & Minor (US), Medline Industries, LP. (US), McKesson Corporation (US), and Mölnlycke AB (Sweden).
Research Coverage
This report examines the surgical gowns and drapes market in terms of product type, material, sterility, application, end user, and regions. The report also examines key factors (including drivers, restraints, opportunities, and challenges) influencing market growth and provides an in-depth analysis of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets in terms of their individual growth trends. It forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms and smaller entrants to gauge the market’s pulse, which in turn will help them garner a larger market share. Firms purchasing the report could use one or more strategies mentioned below to strengthen their market presence.
This report provides insights into the following pointers:
- Analysis of key Drivers (Growing prevalence of HAIs, Increasing number of surgical procedures, Rising focus on infection prevention protocols, Expansion of ambulatory surgical centers) Restraints (Reuse of surgical gowns and drapes in developing regions, High cost of premium disposable products) Opportunities (Growth opportunities in emerging countries, Adoption of advanced fabric technologies) Challenges (Supply chain volatility in raw materials, Quality inconsistency among low-cost suppliers)
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the surgical gowns and drapes market
- Product Development/Innovation: Detailed insights into the upcoming trends, R&D activities, and product launches in the surgical gowns and drapes market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the surgical gowns and drapes market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players, such as Cardinal Health (US), Owens & Minor (US), Medline Industries, LP. (US), McKesson Corporation (US), and Mölnlycke AB (Sweden)
Table of Contents
1 INTRODUCTION 35
1.1 STUDY OBJECTIVES 35
1.2 MARKET DEFINITION 35
1.3 STUDY SCOPE 36
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 36
1.3.2 INCLUSIONS AND EXCLUSIONS 37
1.3.3 YEARS CONSIDERED 38
1.4 CURRENCY CONSIDERED 38
1.5 STAKEHOLDERS 38
1.6 SUMMARY OF CHANGES 38
2 EXECUTIVE SUMMARY 40
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 40
2.2 KEY MARKET PARTICIPANTS: INSIGHTS AND STRATEGIC DEVELOPMENTS 41
2.3 DISRUPTIVE TRENDS SHAPING MARKET 41
2.4 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS 42
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 43
3 PREMIUM INSIGHTS 44
3.1 SURGICAL GOWNS AND DRAPES MARKET OVERVIEW 44
3.2 SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE, 2025 VS. 2030 45
3.3 SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL, 2025 VS. 2030 45
3.4 SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY, 2025 VS. 2030 46
3.5 SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION, 2025 VS. 2030 46
3.6 SURGICAL GOWNS AND DRAPES MARKET, BY END USER, 2025 VS. 2030 47
3.7 SURGICAL GOWNS AND DRAPES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 47
4 MARKET OVERVIEW 48
4.1 INTRODUCTION 48
4.2 MARKET DYNAMICS 48
4.2.1 DRIVERS 49
4.2.1.1 Rising prevalence of healthcare-associated infections 49
4.2.1.2 Increasing number of surgical procedures 50
4.2.1.3 Growing focus on infection prevention protocols 51
4.2.1.4 Expansion of ambulatory surgical centers 52
4.2.2 RESTRAINTS 52
4.2.2.1 Reuse of surgical gowns and drapes in developing regions 52
4.2.2.2 High cost of premium disposable products 52
4.2.3 OPPORTUNITIES 53
4.2.3.1 Growth opportunities in emerging countries 53
4.2.3.2 Adoption of advanced fabric technologies 53
4.2.4 CHALLENGES 54
4.2.4.1 Supply chain volatility in raw materials 54
4.2.4.2 Quality inconsistency among low-cost suppliers 54
4.3 UNMET NEEDS AND WHITE SPACES 55
4.3.1 UNMET NEEDS IN SURGICAL GOWNS AND DRAPES MARKET 55
4.3.2 WHITE SPACE OPPORTUNITIES 55
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 56
4.4.1 INTERCONNECTED MARKETS 56
4.4.2 CROSS-SECTOR OPPORTUNITIES 57
4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS 57
4.5.1 KEY MOVES AND STRATEGIC FOCUS 57
5 INDUSTRY TRENDS 59
5.1 PORTER’S FIVE FORCES ANALYSIS 59
5.1.1 THREAT OF NEW ENTRANTS 60
5.1.2 THREAT OF SUBSTITUTES 60
5.1.3 BARGAINING POWER OF BUYERS 60
5.1.4 BARGAINING POWER OF SUPPLIERS 60
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 61
5.2 MACROECONOMIC INDICATORS 61
5.2.1 INTRODUCTION 61
5.2.2 GDP TRENDS AND FORECAST 61
5.3 SUPPLY CHAIN ANALYSIS 64
5.4 VALUE CHAIN ANALYSIS 65
5.5 ECOSYSTEM ANALYSIS 67
5.6 PRICING ANALYSIS 68
5.6.1 AVERAGE SELLING PRICE TREND, BY PRODUCT 68
5.6.2 AVERAGE SELLING PRICE TREND, BY KEY PLAYER 68
5.6.3 AVERAGE SELLING PRICE TREND, BY REGION 69
5.7 TRADE ANALYSIS 70
5.7.1 IMPORT SCENARIO (HS CODE 621010) 70
5.7.2 EXPORT SCENARIO (HS CODE 621010) 71
5.8 KEY CONFERENCES AND EVENTS, 2025–2026 71
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 72
5.10 INVESTMENT AND FUNDING SCENARIO 73
5.11 CASE STUDY ANALYSIS 73
5.11.1 CASE STUDY 1: COST BENEFIT ANALYSIS OF SURGICAL GOWN
AND DRAPE SELECTION 73
5.11.2 CASE STUDY 2: COMPARE IMPACT AND COST-EFFECTIVENESS
LONG FIBER POLYESTER VS. COTTON FABRIC DRAPES 74
5.11.3 CASE STUDY 3: EVALUATE AND COMPARE PERFORMANCE OF DISPOSABLE VS. REUSABLE MEDICAL GOWNS 75
5.12 IMPACT OF 2025 US TARIFFS ON SURGICAL GOWNS AND DRAPES MARKET 75
5.12.1 INTRODUCTION 75
5.12.2 KEY TARIFF RATES 76
5.12.3 PRICE IMPACT ANALYSIS 77
5.12.4 KEY IMPACT ON COUNTRY/REGION 77
5.12.4.1 North America 77
5.12.4.2 Europe 77
5.12.4.3 Asia Pacific 77
5.12.5 IMPACT ON END-USE INDUSTRIES 78
5.12.5.1 Hospitals 78
5.12.5.2 Ambulatory Surgical Centers (ASCs) 78
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 79
6.1 KEY EMERGING TECHNOLOGIES 79
6.1.1 SMART TEXTILES (E-TEXTILES) 79
6.1.2 BIODEGRADABLE AND COMPOSTABLE MATERIALS 79
6.1.3 ANTIMICROBIAL AND ANTIVIRAL COATINGS 79
6.2 COMPLEMENTARY TECHNOLOGIES 80
6.2.1 STERILIZATION TECHNOLOGIES 80
6.2.2 REUSABLE SURGICAL TEXTILES 80
6.3 TECHNOLOGY/PRODUCT ROADMAP 81
6.3.1 SHORT-TERM (2025–2027) | PROCESS IMPROVEMENT & STANDARDIZATION 81
6.3.2 MID-TERM (2027–2030) | MATERIAL DIVERSIFICATION & SUSTAINABILITY 81
6.3.3 LONG-TERM (2030–2035+) | HIGH-PERFORMANCE & ECO-EFFICIENT LABWARE 82
6.4 TECHNOLOGY/PRODUCT ROADMAP 83
6.5 PATENT ANALYSIS 84
6.6 FUTURE APPLICATIONS 86
6.7 IMPACT OF AI/GENERATIVE AI ON SURGICAL GOWNS AND DRAPES MARKET 86
6.7.1 TOP USE CASES AND MARKET POTENTIAL 87
6.7.2 BEST PRACTICES IN SURGICAL GOWNS AND DRAPES MARKET 87
6.7.3 FUTURE OF AI IN SURGICAL GOWNS AND DRAPES MARKET 88
7 SUSTAINABILITY AND REGULATORY LANDSCAPE 89
7.1 REGIONAL REGULATIONS AND COMPLIANCE 89
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89
7.1.2 INDUSTRY STANDARDS 91
7.2 SUSTAINABILITY INITIATIVES 91
7.2.1 ENVIRONMENTAL IMPACT AND ECO-FRIENDLY INITIATIVES IN SURGICAL GOWNS AND DRAPES 91
7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 93
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 94
8.1 DECISION-MAKING PROCESS 94
8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 94
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 94
8.2.2 BUYING CRITERIA 95
8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES 96
8.4 UNMET NEEDS IN VARIOUS END-USE INDUSTRIES 97
8.5 MARKET PROFITABILITY 98
8.5.1 REVENUE POTENTIAL 98
8.5.2 COST DYNAMICS 98
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 98
9 SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE 100
9.1 INTRODUCTION 101
9.2 SURGICAL DRAPES 101
9.2.1 DISPOSABLE DRAPES 105
9.2.1.1 Increasing volume of surgeries and growing focus on infection prevention to drive market 105
9.2.2 REUSABLE DRAPES 107
9.2.2.1 Durability and sustainability to contribute to growth 107
9.3 SURGICAL GOWNS 110
9.3.1 USAGE PATTERN 114
9.3.1.1 Disposable gowns 114
9.3.1.1.1 Convenience and single-use nature to foster growth 114
9.3.1.2 Reusable gowns 117
9.3.1.2.1 Long-term cost-effectiveness to encourage growth 117
9.3.2 TYPE 120
9.3.2.1 Standard performance gowns 121
9.3.2.1.1 Increasing use of standard performance gowns in
low-risk procedures to favor growth 121
9.3.2.2 Reinforced gowns 123
9.3.2.2.1 Rising demand for reinforced gowns to protect healthcare workers during moderate-risk surgical procedures to boost market 123
9.3.2.3 High-performance gowns 126
9.3.2.3.1 Lightweight and breathable properties to accelerate growth 126
10 SURGICAL GOWNS AND DRAPES MARKET: VOLUME ANALYSIS 129
10.1 INTRODUCTION 129
10.1.1 US: TOTAL VOLUME OF SURGICAL DRAPES, BY APPLICATION,
2023–2030 (MILLION UNITS) 129
10.1.2 US: TOTAL VOLUME OF SURGICAL GOWNS, BY APPLICATION,
2023–2030 (MILLION UNITS) 130
11 SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL 131
11.1 INTRODUCTION 132
11.2 NON-WOVEN MATERIALS 133
11.2.1 POLYPROPYLENE (PP) 135
11.2.1.1 Ability to offer varying degrees of fluid resistance, breathability, and comfort to fuel market 135
11.2.2 POLYETHYLENE (PE) 138
11.2.2.1 Low-friction surface and ease of manufacturing to spur growth 138
11.2.3 SPUNBOND-MELTBLOWN-SPUNBOND (SMS) 140
11.2.3.1 Enhanced durability and resistance to stimulate growth 140
11.2.4 SPUNLACE MATERIALS 143
11.2.4.1 Growing adoption of non-wovens in single-use medical barriers to drive market 143
11.2.5 OTHER NON-WOVEN MATERIALS 146
11.3 WOVEN FABRICS 149
11.3.1 COTTON 152
11.3.1.1 Improved air circulation and compatibility with sensitive skin to boost market 152
11.3.2 POLYESTER-COTTON BLENDS 154
11.3.2.1 Higher resistance to wrinkles, abrasion, and shrinkage to aid growth 154
11.3.3 POLYESTER 157
11.3.3.1 High level of structural integrity to favor growth 157
11.3.4 MICROFIBER FABRICS 159
11.3.4.1 Growing patient volume to drive market 159
11.3.5 LAMINATED/COATED MATERIALS 162
11.3.5.1 Enhanced protective qualities and durability to promote growth 162
11.4 BIODEGRADABLE MATERIALS 165
11.4.1 RISING GERIATRIC POPULATION AND HIGH INCIDENCE OF
EPILEPSY TO DRIVE MARKET 165
12 SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY 168
12.1 INTRODUCTION 169
12.2 STERILE PRODUCTS 169
12.2.1 INCREASING FOCUS ON REDUCING RISK OF INFECTIONS TO AID GROWTH 169
12.3 NON-STERILE PRODUCTS 172
12.3.1 RISING POPULARITY IN PATIENT WARDS AND EMERGENCY ROOMS TO EXPEDITE GROWTH 172
13 SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION 176
13.1 INTRODUCTION 177
13.2 CARDIOVASCULAR APPLICATIONS 177
13.2.1 GROWING INCIDENCE OF CARDIOVASCULAR DISEASES TO FUEL MARKET 177
13.3 GENERAL SURGERY 180
13.3.1 INCREASING VOLUME OF GENERAL SURGERIES TO SPUR GROWTH 180
13.4 GYNECOLOGY 182
13.4.1 RISING C-SECTION AND HYSTERECTOMY CASES TO BOLSTER GROWTH 182
13.5 OPHTHALMOLOGY 185
13.5.1 INCREASING PREVALENCE OF EYE CONDITIONS TO AID GROWTH 185
13.6 LITHOTOMY & LAPAROSCOPY 187
13.6.1 QUICK RECOVERY TIMES AND REDUCED COMPLICATIONS
TO FACILITATE GROWTH 187
13.7 OTHER APPLICATIONS 190
14 SURGICAL GOWNS AND DRAPES MARKET, BY END USER 194
14.1 INTRODUCTION 195
14.2 HOSPITALS 195
14.2.1 INCREASING NUMBER OF SURGERIES PERFORMED GLOBALLY TO PROMOTE GROWTH 195
14.3 AMBULATORY SURGICAL CENTERS 198
14.3.1 RISING FOCUS ON IMPROVED CARE QUALITY AND REDUCED PROCEDURAL COSTS TO BOOST MARKET 198
14.4 OTHER END USERS 201
15 SURGICAL GOWNS AND DRAPES MARKET, BY REGION 204
15.1 INTRODUCTION 205
15.2 NORTH AMERICA 205
15.2.1 US 210
15.2.1.1 Growing cases of healthcare-associated infections to drive market 210
15.2.2 CANADA 213
15.2.2.1 Rising geriatric population to support growth 213
15.3 EUROPE 217
15.3.1 GERMANY 221
15.3.1.1 Growing adoption of hospital disinfection and surveillance systems to boost market 221
15.3.2 UK 226
15.3.2.1 Increasing focus on comprehensive, data-driven infection control strategies to fuel market 226
15.3.3 FRANCE 230
15.3.3.1 Stringent regulatory guidelines for infection control product commercialization to aid growth 230
15.3.4 ITALY 233
15.3.4.1 Increasing establishment of long-term care facilities to boost market 233
15.3.5 SPAIN 237
15.3.5.1 Increasing incidence of chronic diseases to spur growth 237
15.3.6 REST OF EUROPE 241
15.4 ASIA PACIFIC 245
15.4.1 JAPAN 250
15.4.1.1 Increasing elderly population and healthcare expenditure to drive market 250
15.4.2 CHINA 254
15.4.2.1 Rising healthcare spending and increasing prevalence of chronic diseases to drive market 254
15.4.3 INDIA 257
15.4.3.1 Extensive patient population to contribute to growth 257
15.4.4 AUSTRALIA 262
15.4.4.1 Increasing demand for healthcare services to facilitate growth 262
15.4.5 REST OF ASIA PACIFIC 266
15.5 LATIN AMERICA 270
15.5.1 BRAZIL 274
15.5.1.1 Robust pharmaceutical and biotechnology industries to drive market 274
15.5.2 MEXICO 278
15.5.2.1 Changing demographic trend to encourage growth 278
15.5.3 REST OF LATIN AMERICA 281
15.6 MIDDLE EAST & AFRICA 286
16 COMPETITIVE LANDSCAPE 290
16.1 OVERVIEW 290
16.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–2025 290
16.3 REVENUE ANALYSIS, 2022–2024 291
16.4 MARKET SHARE ANALYSIS, 2024 292
16.5 BRAND/PRODUCT COMPARISON 295
16.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 295
16.6.1 STARS 296
16.6.2 EMERGING LEADERS 296
16.6.3 PERVASIVE PLAYERS 296
16.6.4 PARTICIPANTS 296
16.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 298
16.6.5.1 Company footprint 298
16.6.5.2 Region footprint 299
16.6.5.3 Product type footprint 300
16.6.5.4 Application footprint 301
16.6.5.5 End-user footprint 302
16.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 303
16.7.1 PROGRESSIVE COMPANIES 303
16.7.2 RESPONSIVE COMPANIES 303
16.7.3 DYNAMIC COMPANIES 303
16.7.4 STARTING BLOCKS 303
16.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 305
16.7.5.1 Detailed list of key startups/SMEs 305
16.7.5.2 Competitive benchmarking of key startups/SMEs 306
16.8 COMPANY VALUATION AND FINANCIAL METRICS 307
16.9 COMPETITIVE SCENARIO 308
16.9.1 PRODUCT LAUNCHES AND APPROVALS 308
16.9.2 DEALS 308
16.9.3 EXPANSIONS 309
16.9.4 OTHER DEVELOPMENTS 310
17 COMPANY PROFILES 311
17.1 KEY PLAYERS 311
17.1.1 CARDINAL HEALTH 311
17.1.1.1 Business overview 311
17.1.1.2 Products offered 312
17.1.1.3 Recent developments 313
17.1.1.3.1 Product launches and approvals 313
17.1.1.3.2 Expansions 314
17.1.1.4 MnM view 314
17.1.1.4.1 Key strengths/Right to win 314
17.1.1.4.2 Strategic choices 314
17.1.1.4.3 Weaknesses/Competitive threats 314
17.1.2 MEDLINE INDUSTRIES, LP 315
17.1.2.1 Business overview 315
17.1.2.2 Products offered 315
17.1.2.3 Recent developments 317
17.1.2.3.1 Deals 317
17.1.2.3.2 Other developments 317
17.1.2.4 MnM view 317
17.1.2.4.1 Key strengths/Right to win 317
17.1.2.4.2 Strategic choices 317
17.1.2.4.3 Weaknesses/Competitive threats 318
17.1.3 OWENS & MINOR 319
17.1.3.1 Business overview 319
17.1.3.2 Products offered 321
17.1.3.3 MnM view 322
17.1.3.3.1 Key strengths/Right to win 322
17.1.3.3.2 Strategic choices 322
17.1.3.3.3 Weaknesses/Competitive threats 322
17.1.4 MCKESSON CORPORATION 323
17.1.4.1 Business overview 323
17.1.4.2 Products offered 324
17.1.4.3 MnM view 325
17.1.4.3.1 Key strengths/Right to win 325
17.1.4.3.2 Strategic choices 325
17.1.4.3.3 Weaknesses/Competitive threats 325
17.1.5 MÖLNLYCKE AB 326
17.1.5.1 Business overview 326
17.1.5.2 Products offered 327
17.1.5.3 MnM view 328
17.1.5.3.1 Key strengths/Right to win 328
17.1.5.3.2 Strategic choices 328
17.1.5.3.3 Weaknesses/Competitive threats 328
17.1.6 SOLVENTUM 329
17.1.6.1 Business overview 329
17.1.6.2 Products offered 330
17.1.6.3 Recent developments 331
17.1.6.3.1 Other developments 331
17.1.7 PAUL HARTMANN AG 332
17.1.7.1 Business overview 332
17.1.7.2 Products offered 333
17.1.7.3 Recent developments 334
17.1.7.3.1 Deals 334
17.1.8 WINNER MEDICAL, CO., LTD. 335
17.1.8.1 Business overview 335
17.1.8.2 Products offered 337
17.1.8.3 Recent developments 337
17.1.8.3.1 Deals 337
17.1.9 STERIS 339
17.1.9.1 Business overview 339
17.1.9.2 Products offered 340
17.1.10 ALPHAPROTECH 341
17.1.10.1 Business overview 341
17.1.10.2 Products offered 342
17.1.11 HENRY SCHEIN 343
17.1.11.1 Business overview 343
17.1.11.2 Products offered 344
17.1.12 B.BRAUN SE 345
17.1.12.1 Business overview 345
17.1.12.2 Products offered 346
17.1.13 BOSTON SCIENTIFIC CORPORATION 347
17.1.13.1 Business overview 347
17.1.13.2 Products offered 348
17.2 OTHER PLAYERS 349
17.2.1 LOHMANN & RAUSCHER GMBH & CO. KG 349
17.2.2 STANDARD TEXTILE CO., INC. 350
17.2.3 PLURITEX S.R.L. 351
17.2.4 MEDICA EUROPE BV 352
17.2.5 AMARYLLIS HEALTHCARE PVT. LTD. 353
17.2.6 STERIMED GROUP 354
17.2.7 GPC MEDICAL 355
17.2.8 ALLESET 356
17.2.9 BOEN HEALTHCARE CO., LTD. 357
17.2.10 PRIONTEX 358
17.2.11 EURONDA SPA 359
17.2.12 TIDI PRODUCTS, LLC. 360
18 RESEARCH METHODOLOGY 361
18.1 RESEARCH DATA 361
18.1.1 SECONDARY DATA 362
18.1.1.1 List of secondary sources 362
18.1.1.2 Key data from secondary sources 362
18.1.2 PRIMARY DATA 363
18.1.2.1 List of primary sources 363
18.1.2.2 Key data from primary sources 364
18.1.2.3 Breakdown of primary interviews 365
18.1.2.4 Key industry insights 365
18.2 MARKET SIZE ESTIMATION 366
18.2.1 BOTTOM-UP APPROACH 366
18.2.1.1 Approach 1: Revenue estimation of key players 366
18.2.1.2 Approach 2: Study of annual reports and investor presentations 366
18.2.1.3 Approach 3: Primary interviews 367
18.2.1.4 Growth forecast 367
18.2.1.5 CAGR projections 367
18.2.2 TOP-DOWN APPROACH 368
18.3 DATA TRIANGULATION 369
18.4 RESEARCH ASSUMPTIONS 369
18.4.1 STUDY-RELATED ASSUMPTIONS 369
18.4.2 PARAMETRIC ASSUMPTIONS 370
18.4.3 GROWTH RATE ASSUMPTIONS 371
18.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT 371
18.5.1 RESEARCH LIMITATIONS 371
18.5.2 RISK ASSESSMENT 371
19 APPENDIX 372
19.1 DISCUSSION GUIDE 372
19.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 375
19.3 CUSTOMIZATION OPTIONS 377
19.4 RELATED REPORTS 377
19.5 AUTHOR DETAILS 378
LIST OF TABLES
TABLE 1 SURGICAL DRAPES AND GOWNS MARKET: INCLUSIONS AND EXCLUSIONS 37
TABLE 2 EUROPE: PREVALENCE OF HEALTHCARE-ASSOCIATED INFECTIONS IN ACUTE CARE HOSPITALS, BY TYPE, 2022–2023 49
TABLE 3 GERMANY: SURGERY TYPES FOR INPATIENT HOSPITAL VISITS, 2023 51
TABLE 4 IMPACT OF PORTER’S FORCES ON SURGICAL GOWNS AND DRAPES MARKET 60
TABLE 5 GDP PERCENTAGE CHANGE (%), BY KEY COUNTRY, 2023–2030 61
TABLE 6 NORTH AMERICA: MACROECONOMIC INDICATORS 62
TABLE 7 EUROPE: MACROECONOMIC INDICATORS 63
TABLE 8 ASIA PACIFIC: MACROECONOMIC INDICATORS 63
TABLE 9 LATIN AMERICA: MACROECONOMIC INDICATORS 63
TABLE 10 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 63
TABLE 11 SURGICAL GOWNS AND DRAPES MARKET: ROLE OF COMPANIES IN ECOSYSTEM 67
TABLE 12 AVERAGE SELLING PRICING TREND OF SURGICAL GOWNS AND
DRAPES, BY PRODUCT, 2023–2025 (USD) 68
TABLE 13 AVERAGE SELLING PRICE TREND OF SURGICAL GOWNS, BY KEY PLAYER,
2023–2025 (USD) 69
TABLE 14 AVERAGE SELLING PRICE TREND OF SURGICAL GOWNS AND DRAPES PRODUCTS, BY REGION, 2023–2025 (USD) 70
TABLE 15 IMPORT DATA FOR HS CODE 621010-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION) 70
TABLE 16 EXPORT DATA FOR HS CODE 621010-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION) 71
TABLE 17 SURGICAL GOWNS AND DRAPES MARKET: KEY CONFERENCES
AND EVENTS, 2025–2027 71
TABLE 18 US-ADJUSTED RECIPROCAL TARIFF RATES 76
TABLE 19 SURGICAL GOWNS AND DRAPES MARKET: LIST OF MAJOR PATENTS, 2023–2025 85
TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 89
TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 89
TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 90
TABLE 23 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 90
TABLE 24 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 91
TABLE 25 GLOBAL STANDARDS IN SURGICAL GOWNS AND DRAPES MARKET 91
TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT TYPE (%) 95
TABLE 27 KEY BUYING CRITERIA, BY PRODUCT TYPE 95
TABLE 28 ADOPTION BARRIERS AND INTERNAL CHALLENGES 96
TABLE 29 SURGICAL GOWNS AND DRAPES MARKET: UNMET NEEDS IN VARIOUS
END-USE INDUSTRIES 97
TABLE 30 SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 101
TABLE 31 SURGICAL DRAPES OFFERED BY MAJOR COMPANIES 102
TABLE 32 SURGICAL DRAPES MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 102
TABLE 33 SURGICAL DRAPES MARKET, BY REGION, 2023–2030 (USD MILLION) 103
TABLE 34 NORTH AMERICA: SURGICAL DRAPES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 103
TABLE 35 EUROPE: SURGICAL DRAPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 104
TABLE 36 ASIA PACIFIC: SURGICAL DRAPES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 104
TABLE 37 LATIN AMERICA: SURGICAL DRAPES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 105
TABLE 38 SURGICAL DRAPES MARKET FOR DISPOSABLE DRAPES, BY REGION,
2023–2030 (USD MILLION) 105
TABLE 39 NORTH AMERICA: SURGICAL DRAPES MARKET FOR DISPOSABLE DRAPES,
BY COUNTRY, 2023–2030 (USD MILLION) 106
TABLE 40 EUROPE: SURGICAL DRAPES MARKET FOR DISPOSABLE DRAPES,
BY COUNTRY, 2023–2030 (USD MILLION) 106
TABLE 41 ASIA PACIFIC: SURGICAL DRAPES MARKET FOR DISPOSABLE DRAPES,
BY COUNTRY, 2023–2030 (USD MILLION) 107
TABLE 42 LATIN AMERICA: SURGICAL DRAPES MARKET FOR DISPOSABLE DRAPES,
BY COUNTRY, 2023–2030 (USD MILLION) 107
TABLE 43 SURGICAL DRAPES MARKET FOR REUSABLE DRAPES, BY REGION,
2023–2030 (USD MILLION) 108
TABLE 44 NORTH AMERICA: SURGICAL DRAPES MARKET FOR REUSABLE DRAPES,
BY COUNTRY, 2023–2030 (USD MILLION) 108
TABLE 45 EUROPE: SURGICAL DRAPES MARKET FOR REUSABLE DRAPES, BY COUNTRY, 2023–2030 (USD MILLION) 109
TABLE 46 ASIA PACIFIC: SURGICAL DRAPES MARKET FOR REUSABLE DRAPES, BY COUNTRY, 2023–2030 (USD MILLION) 109
TABLE 47 LATIN AMERICA: SURGICAL DRAPES MARKET FOR REUSABLE DRAPES,
BY COUNTRY, 2023–2030 (USD MILLION) 110
TABLE 48 LEVELS OF SURGICAL GOWNS 111
TABLE 49 SURGICAL GOWNS OFFERED BY MAJOR COMPANIES 111
TABLE 50 SURGICAL GOWNS MARKET, BY REGION, 2023–2030 (USD MILLION) 112
TABLE 51 NORTH AMERICA: SURGICAL GOWNS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 112
TABLE 52 EUROPE: SURGICAL GOWNS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 113
TABLE 53 ASIA PACIFIC: SURGICAL GOWNS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 113
TABLE 54 LATIN AMERICA: SURGICAL GOWNS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 114
TABLE 55 SURGICAL GOWNS MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 114
TABLE 56 SURGICAL GOWNS MARKET FOR DISPOSABLE GOWNS, BY REGION,
2023–2030 (USD MILLION) 115
TABLE 57 NORTH AMERICA: SURGICAL GOWNS MARKET FOR DISPOSABLE GOWNS,
BY COUNTRY, 2023–2030 (USD MILLION) 115
TABLE 58 EUROPE: SURGICAL GOWNS MARKET FOR DISPOSABLE GOWNS,
BY COUNTRY, 2023–2030 (USD MILLION) 116
TABLE 59 ASIA PACIFIC: SURGICAL GOWNS MARKET FOR DISPOSABLE GOWNS,
BY COUNTRY, 2023–2030 (USD MILLION) 116
TABLE 60 LATIN AMERICA: SURGICAL GOWNS MARKET FOR DISPOSABLE GOWNS,
BY COUNTRY, 2023–2030 (USD MILLION) 117
TABLE 61 SURGICAL GOWNS MARKET FOR REUSABLE GOWNS, BY REGION,
2023–2030 (USD MILLION) 118
TABLE 62 NORTH AMERICA: SURGICAL GOWNS MARKET FOR REUSABLE GOWNS,
BY COUNTRY, 2023–2030 (USD MILLION) 118
TABLE 63 EUROPE: SURGICAL GOWNS MARKET FOR REUSABLE GOWNS,
BY COUNTRY, 2023–2030 (USD MILLION) 119
TABLE 64 ASIA PACIFIC: SURGICAL GOWNS MARKET FOR REUSABLE GOWNS,
BY COUNTRY, 2023–2030 (USD MILLION) 119
TABLE 65 LATIN AMERICA: SURGICAL GOWNS MARKET FOR REUSABLE GOWNS,
BY COUNTRY, 2023–2030 (USD MILLION) 120
TABLE 66 SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 120
TABLE 67 SURGICAL GOWNS MARKET FOR STANDARD PERFORMANCE GOWNS,
BY REGION, 2023–2030 (USD MILLION) 121
TABLE 68 NORTH AMERICA: SURGICAL GOWNS MARKET FOR STANDARD PERFORMANCE GOWNS, BY COUNTRY, 2023–2030 (USD MILLION) 121
TABLE 69 EUROPE: SURGICAL GOWNS MARKET FOR STANDARD PERFORMANCE GOWNS,
BY COUNTRY, 2023–2030 (USD MILLION) 122
TABLE 70 ASIA PACIFIC: SURGICAL GOWNS MARKET FOR STANDARD PERFORMANCE GOWNS, BY COUNTRY, 2023–2030 (USD MILLION) 122
TABLE 71 LATIN AMERICA: SURGICAL GOWNS MARKET FOR STANDARD PERFORMANCE GOWNS, BY COUNTRY, 2023–2030 (USD MILLION) 123
TABLE 72 SURGICAL GOWNS MARKET FOR REINFORCED GOWNS, BY REGION,
2023–2030 (USD MILLION) 123
TABLE 73 NORTH AMERICA: SURGICAL GOWNS MARKET FOR REINFORCED GOWNS,
BY COUNTRY, 2023–2030 (USD MILLION) 124
TABLE 74 EUROPE: SURGICAL GOWNS MARKET FOR REINFORCED GOWNS,
BY COUNTRY, 2023–2030 (USD MILLION) 124
TABLE 75 ASIA PACIFIC: SURGICAL GOWNS MARKET FOR REINFORCED GOWNS,
BY COUNTRY, 2023–2030 (USD MILLION) 125
TABLE 76 LATIN AMERICA: SURGICAL GOWNS MARKET FOR REINFORCED GOWNS,
BY COUNTRY, 2023–2030 (USD MILLION) 125
TABLE 77 SURGICAL GOWNS MARKET FOR HIGH-PERFORMANCE GOWNS, BY REGION, 2023–2030 (USD MILLION) 126
TABLE 78 NORTH AMERICA: SURGICAL GOWNS MARKET FOR HIGH-PERFORMANCE GOWNS, BY COUNTRY, 2023–2030 (USD MILLION) 126
TABLE 79 EUROPE: SURGICAL GOWNS MARKET FOR HIGH-PERFORMANCE GOWNS,
BY COUNTRY, 2023–2030 (USD MILLION) 127
TABLE 80 ASIA PACIFIC: SURGICAL GOWNS MARKET FOR HIGH-PERFORMANCE GOWNS,
BY COUNTRY, 2023–2030 (USD MILLION) 127
TABLE 81 LATIN AMERICA: SURGICAL GOWNS MARKET FOR HIGH-PERFORMANCE GOWNS, BY COUNTRY, 2023–2030 (USD MILLION) 128
TABLE 82 VOLUME OF SURGICAL DRAPES IN THE US, BY APPLICATION
2023–2030 (MILLION UNITS) 129
TABLE 83 VOLUME OF SURGICAL GOWNS IN THE US, BY APPLICATION
2023–2030 (MILLION UNITS) 130
TABLE 84 SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL,
2023–2030 (USD MILLION) 132
TABLE 85 SURGICAL GOWNS AND DRAPES MARKET FOR NON-WOVEN MATERIALS,
BY TYPE, 2023–2030 (USD MILLION) 133
TABLE 86 SURGICAL GOWNS AND DRAPES MARKET FOR NON-WOVEN MATERIALS,
BY REGION, 2023–2030 (USD MILLION) 133
TABLE 87 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR NON-WOVEN MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 134
TABLE 88 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR NON-WOVEN MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 134
TABLE 89 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR NON-WOVEN MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 135
TABLE 90 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR NON-WOVEN MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 135
TABLE 91 SURGICAL GOWNS AND DRAPES MARKET FOR POLYPROPYLENE, BY REGION, 2023–2030 (USD MILLION) 136
TABLE 92 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR POLYPROPYLENE, BY COUNTRY, 2023–2030 (USD MILLION) 136
TABLE 93 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR POLYPROPYLENE,
BY COUNTRY, 2023–2030 (USD MILLION) 137
TABLE 94 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR POLYPROPYLENE,
BY COUNTRY, 2023–2030 (USD MILLION) 137
TABLE 95 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR POLYPROPYLENE, BY COUNTRY, 2023–2030 (USD MILLION) 138
TABLE 96 SURGICAL GOWNS AND DRAPES MARKET FOR POLYETHYLENE, BY REGION, 2023–2030 (USD MILLION) 138
TABLE 97 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR POLYETHYLENE, BY COUNTRY, 2023–2030 (USD MILLION) 139
TABLE 98 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR POLYETHYLENE,
BY COUNTRY, 2023–2030 (USD MILLION) 139
TABLE 99 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR POLYETHYLENE,
BY COUNTRY, 2023–2030 (USD MILLION) 140
TABLE 100 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR POLYETHYLENE, BY COUNTRY, 2023–2030 (USD MILLION) 140
TABLE 101 SURGICAL GOWNS AND DRAPES MARKET FOR SPUNBOND-MELTBLOWN-SPUNBOND MATERIALS, BY REGION, 2023–2030 (USD MILLION) 141
TABLE 102 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR SPUNBOND-MELTBLOWN-SPUNBOND MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 141
TABLE 103 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR SPUNBOND-MELTBLOWN-SPUNBOND MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 142
TABLE 104 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR SPUNBOND-MELTBLOWN-SPUNBOND MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 142
TABLE 105 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR SPUNBOND-MELTBLOWN-SPUNBOND MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 143
TABLE 106 SURGICAL GOWNS AND DRAPES MARKET FOR SPUNLACE MATERIALS, BY REGION, 2023–2030 (USD MILLION) 144
TABLE 107 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR SPUNLACE MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 144
TABLE 108 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR SPUNLACE MATERIALS,
BY COUNTRY, 2023–2030 (USD MILLION) 145
TABLE 109 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR SPUNLACE MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 145
TABLE 110 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR SPUNLACE MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 146
TABLE 111 SURGICAL GOWNS AND DRAPES MARKET FOR OTHER NON-WOVEN MATERIALS,
BY REGION, 2023–2030 (USD MILLION) 147
TABLE 112 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR OTHER NON-WOVEN MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 147
TABLE 113 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR OTHER NON-WOVEN MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 148
TABLE 114 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR OTHER NON-WOVEN MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 148
TABLE 115 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR OTHER NON-WOVEN MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 149
TABLE 116 SURGICAL GOWNS AND DRAPES MARKET FOR WOVEN FABRICS, BY TYPE,
2023–2030 (USD MILLION) 149
TABLE 117 SURGICAL GOWNS AND DRAPES MARKET FOR WOVEN FABRICS, BY REGION, 2023–2030 (USD MILLION) 150
TABLE 118 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR WOVEN FABRICS, BY COUNTRY, 2023–2030 (USD MILLION) 150
TABLE 119 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR WOVEN FABRICS,
BY COUNTRY, 2023–2030 (USD MILLION) 151
TABLE 120 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR WOVEN FABRICS,
BY COUNTRY, 2023–2030 (USD MILLION) 151
TABLE 121 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR WOVEN FABRICS, BY COUNTRY, 2023–2030 (USD MILLION) 152
TABLE 122 SURGICAL GOWNS AND DRAPES MARKET FOR COTTON, BY REGION,
2023–2030 (USD MILLION) 152
TABLE 123 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR COTTON,
BY COUNTRY, 2023–2030 (USD MILLION) 153
TABLE 124 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR COTTON, BY COUNTRY, 2023–2030 (USD MILLION) 153
TABLE 125 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR COTTON,
BY COUNTRY, 2023–2030 (USD MILLION) 154
TABLE 126 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR COTTON,
BY COUNTRY, 2023–2030 (USD MILLION) 154
TABLE 127 SURGICAL GOWNS AND DRAPES MARKET FOR POLYESTER-COTTON BLENDS,
BY REGION, 2023–2030 (USD MILLION) 155
TABLE 128 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR POLYESTER-COTTON BLENDS, BY COUNTRY, 2023–2030 (USD MILLION) 155
TABLE 129 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR POLYESTER-COTTON BLENDS, BY COUNTRY, 2023–2030 (USD MILLION) 156
TABLE 130 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR POLYESTER-COTTON BLENDS, BY COUNTRY, 2023–2030 (USD MILLION) 156
TABLE 131 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR POLYESTER-COTTON BLENDS, BY COUNTRY, 2023–2030 (USD MILLION) 157
TABLE 132 SURGICAL GOWNS AND DRAPES MARKET FOR POLYESTER, BY REGION,
2023–2030 (USD MILLION) 157
TABLE 133 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR POLYESTER,
BY COUNTRY, 2023–2030 (USD MILLION) 158
TABLE 134 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR POLYESTER, BY COUNTRY, 2023–2030 (USD MILLION) 158
TABLE 135 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR POLYESTER,
BY COUNTRY, 2023–2030 (USD MILLION) 159
TABLE 136 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR POLYESTER,
BY COUNTRY, 2023–2030 (USD MILLION) 159
TABLE 137 SURGICAL GOWNS AND DRAPES MARKET FOR MICROFIBER FABRICS, BY REGION, 2023–2030 (USD MILLION) 160
TABLE 138 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR MICROFIBER FABRICS, BY COUNTRY, 2023–2030 (USD MILLION) 160
TABLE 139 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR MICROFIBER FABRICS,
BY COUNTRY, 2023–2030 (USD MILLION) 161
TABLE 140 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR MICROFIBER FABRICS, BY COUNTRY, 2023–2030 (USD MILLION) 161
TABLE 141 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR MICROFIBER FABRICS, BY COUNTRY, 2023–2030 (USD MILLION) 162
TABLE 142 SURGICAL GOWNS AND DRAPES MARKET FOR LAMINATED/COATED MATERIALS, BY REGION, 2023–2030 (USD MILLION) 162
TABLE 143 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR LAMINATED/COATED MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 163
TABLE 144 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR LAMINATED/COATED MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 163
TABLE 145 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR
LAMINATED/COATED MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 164
TABLE 146 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR LAMINATED/COATED MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 164
TABLE 147 SURGICAL GOWNS AND DRAPES MARKET FOR BIODEGRADABLE MATERIALS,
BY REGION, 2023–2030 (USD MILLION) 165
TABLE 148 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR BIODEGRADABLE MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 165
TABLE 149 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR BIODEGRADABLE MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 166
TABLE 150 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR BIODEGRADABLE MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 166
TABLE 151 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR BIODEGRADABLE MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 167
TABLE 152 SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY,
2023–2030 (USD MILLION) 169
TABLE 153 SURGICAL GOWNS AND DRAPES MARKET FOR STERILE PRODUCTS, BY REGION, 2023–2030 (USD MILLION) 170
TABLE 154 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR STERILE PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION) 170
TABLE 155 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR STERILE PRODUCTS,
BY COUNTRY, 2023–2030 (USD MILLION) 171
TABLE 156 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR STERILE PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION) 171
TABLE 157 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR STERILE PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION) 172
TABLE 158 SURGICAL GOWNS AND DRAPES MARKET FOR NON-STERILE PRODUCTS,
BY REGION, 2023–2030 (USD MILLION) 173
TABLE 159 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR NON-STERILE PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION) 173
TABLE 160 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR NON-STERILE PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION) 174
TABLE 161 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR NON-STERILE PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION) 174
TABLE 162 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR NON-STERILE PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION) 175
TABLE 163 SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 177
TABLE 164 SURGICAL GOWNS AND DRAPES MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 178
TABLE 165 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 178
TABLE 166 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 179
TABLE 167 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 179
TABLE 168 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 180
TABLE 169 SURGICAL GOWNS AND DRAPES MARKET FOR GENERAL SURGERY,
BY REGION, 2023–2030 (USD MILLION) 180
TABLE 170 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR GENERAL SURGERY, BY COUNTRY, 2023–2030 (USD MILLION) 181
TABLE 171 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR GENERAL SURGERY,
BY COUNTRY, 2023–2030 (USD MILLION) 181
TABLE 172 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR GENERAL SURGERY, BY COUNTRY, 2023–2030 (USD MILLION) 182
TABLE 173 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR GENERAL SURGERY, BY COUNTRY, 2023–2030 (USD MILLION) 182
TABLE 174 SURGICAL GOWNS AND DRAPES MARKET FOR GYNECOLOGY, BY REGION,
2023–2030 (USD MILLION) 183
TABLE 175 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR GYNECOLOGY,
BY COUNTRY, 2023–2030 (USD MILLION) 183
TABLE 176 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR GYNECOLOGY,
BY COUNTRY, 2023–2030 (USD MILLION) 184
TABLE 177 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR GYNECOLOGY,
BY COUNTRY, 2023–2030 (USD MILLION) 184
TABLE 178 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR GYNECOLOGY,
BY COUNTRY, 2023–2030 (USD MILLION) 185
TABLE 179 SURGICAL GOWNS AND DRAPES MARKET FOR OPHTHALMOLOGY,
BY REGION, 2023–2030 (USD MILLION) 185
TABLE 180 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 186
TABLE 181 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR OPHTHALMOLOGY,
BY COUNTRY, 2023–2030 (USD MILLION) 186
TABLE 182 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR OPHTHALMOLOGY,
BY COUNTRY, 2023–2030 (USD MILLION) 187
TABLE 183 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 187
TABLE 184 SURGICAL GOWNS AND DRAPES MARKET FOR LITHOTOMY & LAPAROSCOPY,
BY REGION, 2023–2030 (USD MILLION) 188
TABLE 185 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR LITHOTOMY & LAPAROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION) 188
TABLE 186 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR LITHOTOMY & LAPAROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION) 189
TABLE 187 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR LITHOTOMY & LAPAROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION) 189
TABLE 188 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR LITHOTOMY & LAPAROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION) 190
TABLE 189 SURGICAL GOWNS AND DRAPES MARKET FOR OTHER APPLICATIONS,
BY REGION, 2023–2030 (USD MILLION) 191
TABLE 190 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET
FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 191
TABLE 191 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2023–2030 (USD MILLION) 192
TABLE 192 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 192
TABLE 193 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 193
TABLE 194 SURGICAL GOWNS AND DRAPES MARKET, BY END USER,
2023–2030 (USD MILLION) 195
TABLE 195 SURGICAL GOWNS AND DRAPES MARKET FOR HOSPITALS, BY REGION,
2023–2030 (USD MILLION) 196
TABLE 196 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR HOSPITALS,
BY COUNTRY, 2023–2030 (USD MILLION) 196
TABLE 197 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR HOSPITALS,
BY COUNTRY, 2023–2030 (USD MILLION) 197
TABLE 198 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR HOSPITALS,
BY COUNTRY, 2023–2030 (USD MILLION) 197
TABLE 199 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR HOSPITALS,
BY COUNTRY, 2023–2030 (USD MILLION) 198
TABLE 200 SURGICAL GOWNS AND DRAPES MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2023–2030 (USD MILLION) 199
TABLE 201 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 199
TABLE 202 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 200
TABLE 203 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 200
TABLE 204 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 201
TABLE 205 SURGICAL GOWNS AND DRAPES MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION) 201
TABLE 206 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR
OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 202
TABLE 207 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR OTHER END USERS,
BY COUNTRY, 2023–2030 (USD MILLION) 202
TABLE 208 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR OTHER
END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 203
TABLE 209 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR
OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 203
TABLE 210 SURGICAL GOWNS AND DRAPES MARKET, BY REGION, 2023–2030 (USD MILLION) 205
TABLE 211 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 207
TABLE 212 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 207
TABLE 213 NORTH AMERICA: SURGICAL DRAPES MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 207
TABLE 214 NORTH AMERICA: SURGICAL GOWNS MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 208
TABLE 215 NORTH AMERICA: SURGICAL GOWNS MARKET, BY TYPE,
2023–2030 (USD MILLION) 208
TABLE 216 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL,
2023–2030 (USD MILLION) 208
TABLE 217 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY,
2023–2030 (USD MILLION) 209
TABLE 218 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 209
TABLE 219 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET, BY END USER,
2023–2030 (USD MILLION) 210
TABLE 220 US: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 211
TABLE 221 US: SURGICAL DRAPES MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 211
TABLE 222 US: SURGICAL GOWNS MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 211
TABLE 223 US: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 212
TABLE 224 US: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL,
2023–2030 (USD MILLION) 212
TABLE 225 US: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY,
2023–2030 (USD MILLION) 212
TABLE 226 US: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 213
TABLE 227 US: SURGICAL GOWNS AND DRAPES MARKET, BY END USER,
2023–2030 (USD MILLION) 213
TABLE 228 CANADA: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 214
TABLE 229 CANADA: SURGICAL DRAPES MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 215
TABLE 230 CANADA: SURGICAL GOWNS MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 215
TABLE 231 CANADA: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 215
TABLE 232 CANADA: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL,
2023–2030 (USD MILLION) 216
TABLE 233 CANADA: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY,
2023–2030 (USD MILLION) 216
TABLE 234 CANADA: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 217
TABLE 235 CANADA: SURGICAL GOWNS AND DRAPES MARKET, BY END USER,
2023–2030 (USD MILLION) 217
TABLE 236 EUROPE: SURGICAL GOWNS AND DRAPES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 218
TABLE 237 EUROPE: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 218
TABLE 238 EUROPE: SURGICAL DRAPES MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 219
TABLE 239 EUROPE: SURGICAL GOWNS MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 219
TABLE 240 EUROPE: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 219
TABLE 241 EUROPE: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL,
2023–2030 (USD MILLION) 220
TABLE 242 EUROPE: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY,
2023–2030 (USD MILLION) 220
TABLE 243 EUROPE: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 221
TABLE 244 EUROPE: SURGICAL GOWNS AND DRAPES MARKET, BY END USER,
2023–2030 (USD MILLION) 221
TABLE 245 GERMANY: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 222
TABLE 246 GERMANY: SURGICAL DRAPES MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 223
TABLE 247 GERMANY: SURGICAL GOWNS MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 223
TABLE 248 GERMANY: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 223
TABLE 249 GERMANY: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL,
2023–2030 (USD MILLION) 224
TABLE 250 GERMANY: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY,
2023–2030 (USD MILLION) 224
TABLE 251 GERMANY: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 225
TABLE 252 GERMANY: SURGICAL GOWNS AND DRAPES MARKET, BY END USER,
2023–2030 (USD MILLION) 225
TABLE 253 UK: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 227
TABLE 254 UK: SURGICAL DRAPES MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 227
TABLE 255 UK: SURGICAL GOWNS MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 227
TABLE 256 UK: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 228
TABLE 257 UK: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL,
2023–2030 (USD MILLION) 228
TABLE 258 UK: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY,
2023–2030 (USD MILLION) 228
TABLE 259 UK: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 229
TABLE 260 UK: SURGICAL GOWNS AND DRAPES MARKET, BY END USER,
2023–2030 (USD MILLION) 229
TABLE 261 FRANCE: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 231
TABLE 262 FRANCE: SURGICAL DRAPES MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 231
TABLE 263 FRANCE: SURGICAL GOWNS MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 231
TABLE 264 FRANCE: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 232
TABLE 265 FRANCE: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL,
2023–2030 (USD MILLION) 232
TABLE 266 FRANCE: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY,
2023–2030 (USD MILLION) 232
TABLE 267 FRANCE: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 233
TABLE 268 FRANCE: SURGICAL GOWNS AND DRAPES MARKET, BY END USER,
2023–2030 (USD MILLION) 233
TABLE 269 ITALY: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 234
TABLE 270 ITALY: SURGICAL DRAPES MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 234
TABLE 271 ITALY: SURGICAL GOWNS MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 235
TABLE 272 ITALY: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 235
TABLE 273 ITALY: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL,
2023–2030 (USD MILLION) 235
TABLE 274 ITALY: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY,
2023–2030 (USD MILLION) 236
TABLE 275 ITALY: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 236
TABLE 276 ITALY: SURGICAL GOWNS AND DRAPES MARKET, BY END USER,
2023–2030 (USD MILLION) 237
TABLE 277 SPAIN: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 238
TABLE 278 SPAIN: SURGICAL DRAPES MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 238
TABLE 279 SPAIN: SURGICAL GOWNS MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 238
TABLE 280 SPAIN: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 239
TABLE 281 SPAIN: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL,
2023–2030 (USD MILLION) 239
TABLE 282 SPAIN: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY,
2023–2030 (USD MILLION) 239
TABLE 283 SPAIN: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 240
TABLE 284 SPAIN: SURGICAL GOWNS AND DRAPES MARKET, BY END USER,
2023–2030 (USD MILLION) 240
TABLE 285 REST OF EUROPE: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 242
TABLE 286 REST OF EUROPE: SURGICAL DRAPES MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 242
TABLE 287 REST OF EUROPE: SURGICAL GOWNS MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 243
TABLE 288 REST OF EUROPE: SURGICAL GOWNS MARKET, BY TYPE,
2023–2030 (USD MILLION) 243
TABLE 289 REST OF EUROPE: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL,
2023–2030 (USD MILLION) 243
TABLE 290 REST OF EUROPE: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY,
2023–2030 (USD MILLION) 244
TABLE 291 REST OF EUROPE: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 244
TABLE 292 REST OF EUROPE: SURGICAL GOWNS AND DRAPES MARKET, BY END USER, 2023–2030 (USD MILLION) 245
TABLE 293 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 246
TABLE 294 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 247
TABLE 295 ASIA PACIFIC: SURGICAL DRAPES MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 247
TABLE 296 ASIA PACIFIC: SURGICAL GOWNS MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 247
TABLE 297 ASIA PACIFIC: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 248
TABLE 298 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL,
2023–2030 (USD MILLION) 248
TABLE 299 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY,
2023–2030 (USD MILLION) 248
TABLE 300 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 249
TABLE 301 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET, BY END USER,
2023–2030 (USD MILLION) 249
TABLE 302 JAPAN: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 250
TABLE 303 JAPAN: SURGICAL DRAPES MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 251
TABLE 304 JAPAN: SURGICAL GOWNS MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 251
TABLE 305 JAPAN: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 251
TABLE 306 JAPAN: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL,
2023–2030 (USD MILLION) 252
TABLE 307 JAPAN: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY,
2023–2030 (USD MILLION) 252
TABLE 308 JAPAN: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 253
TABLE 309 JAPAN: SURGICAL GOWNS AND DRAPES MARKET, BY END USER,
2023–2030 (USD MILLION) 253
TABLE 310 CHINA: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 254
TABLE 311 CHINA: SURGICAL DRAPES MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 255
TABLE 312 CHINA: SURGICAL GOWNS MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 255
TABLE 313 CHINA: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 255
TABLE 314 CHINA: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL,
2023–2030 (USD MILLION) 256
TABLE 315 CHINA: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY,
2023–2030 (USD MILLION) 256
TABLE 316 CHINA: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 257
TABLE 317 CHINA: SURGICAL GOWNS AND DRAPES MARKET, BY END USER,
2023–2030 (USD MILLION) 257
TABLE 318 INDIA: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 258
TABLE 319 INDIA: SURGICAL DRAPES MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 259
TABLE 320 INDIA: SURGICAL GOWNS MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 259
TABLE 321 INDIA: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 259
TABLE 322 INDIA: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL,
2023–2030 (USD MILLION) 260
TABLE 323 INDIA: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY,
2023–2030 (USD MILLION) 260
TABLE 324 INDIA: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 261
TABLE 325 INDIA: SURGICAL GOWNS AND DRAPES MARKET, BY END USER,
2023–2030 (USD MILLION) 261
TABLE 326 AUSTRALIA: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 263
TABLE 327 AUSTRALIA: SURGICAL DRAPES MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 263
TABLE 328 AUSTRALIA: SURGICAL GOWNS MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 263
TABLE 329 AUSTRALIA: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 264
TABLE 330 AUSTRALIA: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL,
2023–2030 (USD MILLION) 264
TABLE 331 AUSTRALIA: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY,
2023–2030 (USD MILLION) 264
TABLE 332 AUSTRALIA: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 265
TABLE 333 AUSTRALIA: SURGICAL GOWNS AND DRAPES MARKET, BY END USER,
2023–2030 (USD MILLION) 265
TABLE 334 REST OF ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 266
TABLE 335 REST OF ASIA PACIFIC: SURGICAL DRAPES MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 267
TABLE 336 REST OF ASIA PACIFIC: SURGICAL GOWNS MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 267
TABLE 337 REST OF ASIA PACIFIC: SURGICAL GOWNS MARKET, BY TYPE,
2023–2030 (USD MILLION) 267
TABLE 338 REST OF ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 268
TABLE 339 REST OF ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY, 2023–2030 (USD MILLION) 268
TABLE 340 REST OF ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 269
TABLE 341 REST OF ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET, BY END USER, 2023–2030 (USD MILLION) 269
TABLE 342 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 270
TABLE 343 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 271
TABLE 344 LATIN AMERICA: SURGICAL DRAPES MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 271
TABLE 345 LATIN AMERICA: SURGICAL GOWNS MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 271
TABLE 346 LATIN AMERICA: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 272
TABLE 347 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL,
2023–2030 (USD MILLION) 272
TABLE 348 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY,
2023–2030 (USD MILLION) 272
TABLE 349 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 273
TABLE 350 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET, BY END USER,
2023–2030 (USD MILLION) 273
TABLE 351 BRAZIL: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 274
TABLE 352 BRAZIL: SURGICAL DRAPES MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 275
TABLE 353 BRAZIL: SURGICAL GOWNS MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 275
TABLE 354 BRAZIL: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 275
TABLE 355 BRAZIL: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL,
2023–2030 (USD MILLION) 276
TABLE 356 BRAZIL: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY,
2023–2030 (USD MILLION) 276
TABLE 357 BRAZIL: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 277
TABLE 358 BRAZIL: SURGICAL GOWNS AND DRAPES MARKET, BY END USER,
2023–2030 (USD MILLION) 277
TABLE 359 MEXICO: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 278
TABLE 360 MEXICO: SURGICAL DRAPES MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 279
TABLE 361 MEXICO: SURGICAL GOWNS MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 279
TABLE 362 MEXICO: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 279
TABLE 363 MEXICO: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL,
2023–2030 (USD MILLION) 280
TABLE 364 MEXICO: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY,
2023–2030 (USD MILLION) 280
TABLE 365 MEXICO: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 281
TABLE 366 MEXICO: SURGICAL GOWNS AND DRAPES MARKET, BY END USER,
2023–2030 (USD MILLION) 281
TABLE 367 REST OF LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 282
TABLE 368 REST OF LATIN AMERICA: SURGICAL DRAPES MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 283
TABLE 369 REST OF LATIN AMERICA: SURGICAL GOWNS MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 283
TABLE 370 REST OF LATIN AMERICA: SURGICAL GOWNS MARKET, BY TYPE,
2023–2030 (USD MILLION) 283
TABLE 371 REST OF LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 284
TABLE 372 REST OF LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY, 2023–2030 (USD MILLION) 284
TABLE 373 REST OF LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 285
TABLE 374 REST OF LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET, BY END USER, 2023–2030 (USD MILLION) 285
TABLE 375 MIDDLE EAST & AFRICA: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 286
TABLE 376 MIDDLE EAST & AFRICA: SURGICAL DRAPES MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 287
TABLE 377 MIDDLE EAST & AFRICA: SURGICAL GOWNS MARKET, BY USAGE PATTERN,
2023–2030 (USD MILLION) 287
TABLE 378 MIDDLE EAST & AFRICA: SURGICAL GOWNS MARKET, BY TYPE,
2023–2030 (USD MILLION) 287
TABLE 379 MIDDLE EAST & AFRICA: SURGICAL GOWNS AND DRAPES MARKET,
BY MATERIAL, 2023–2030 (USD MILLION) 288
TABLE 380 MIDDLE EAST & AFRICA: SURGICAL GOWNS AND DRAPES MARKET,
BY STERILITY, 2023–2030 (USD MILLION) 288
TABLE 381 MIDDLE EAST & AFRICA: SURGICAL GOWNS AND DRAPES MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 289
TABLE 382 MIDDLE EAST & AFRICA: SURGICAL GOWNS AND DRAPES MARKET,
BY END USER, 2023–2030 (USD MILLION) 289
TABLE 383 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–2025 290
TABLE 384 SURGICAL GOWNS AND DRAPES MARKET: DEGREE OF COMPETITION 293
TABLE 385 SURGICAL GOWNS AND DRAPES MARKET: REGION FOOTPRINT 299
TABLE 386 SURGICAL GOWNS AND DRAPES MARKET: PRODUCT TYPE FOOTPRINT 300
TABLE 387 SURGICAL GOWNS AND DRAPES MARKET: APPLICATION FOOTPRINT 301
TABLE 388 SURGICAL GOWNS AND DRAPES MARKET: END-USER FOOTPRINT 302
TABLE 389 SURGICAL GOWNS AND DRAPES MARKET: DETAILED LIST OF KEY STARTUPS/SMES 305
TABLE 390 SURGICAL GOWNS AND DRAPES MARKET: COMPETITIVE BENCHMARKING
OF KEY STARTUPS/SMES 306
TABLE 391 SURGICAL GOWNS AND DRAPES MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–OCTOBER 2025 308
TABLE 392 SURGICAL GOWNS AND DRAPES MARKET: DEALS, JANUARY 2022–OCTOBER 2025 308
TABLE 393 SURGICAL GOWNS AND DRAPES MARKET: EXPANSIONS,
JANUARY 2022–OCTOBER 2025 309
TABLE 394 SURGICAL GOWNS AND DRAPES MARKET: OTHER DEVELOPMENTS,
JANUARY 2022–OCTOBER 2025 310
TABLE 395 CARDINAL HEALTH: COMPANY OVERVIEW 311
TABLE 396 CARDINAL HEALTH: PRODUCTS OFFERED 312
TABLE 397 CARDINAL HEALTH: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2022–OCTOBER 2025 313
TABLE 398 CARDINAL HEALTH: EXPANSIONS, JANUARY 2022–OCTOBER 2025 314
TABLE 399 MEDLINE INDUSTRIES, LP: COMPANY OVERVIEW 315
TABLE 400 MEDLINE INDUSTRIES, LP.: PRODUCTS OFFERED 315
TABLE 401 MEDLINE INDUSTRIES, LP: DEALS, JANUARY 2022– OCTOBER 2025 317
TABLE 402 MEDLINE INDUSTRIES, LP: OTHER DEVELOPMENTS,
JANUARY 2022–OCTOBER 2025 317
TABLE 403 OWENS & MINOR: COMPANY OVERVIEW 319
TABLE 404 OWENS & MINOR: PRODUCTS OFFERED 321
TABLE 405 MCKESSON CORPORATION: COMPANY OVERVIEW 323
TABLE 406 MCKESSON CORPORATION: PRODUCTS OFFERED 324
TABLE 407 MÖLNLYCKE AB: COMPANY OVERVIEW 326
TABLE 408 MÖLNLYCKE AB: PRODUCTS OFFERED 327
TABLE 409 SOLVENTUM: COMPANY OVERVIEW 329
TABLE 410 SOLVENTUM: PRODUCTS OFFERED 330
TABLE 411 SOLVENTUM: OTHER DEVELOPMENTS, JANUARY 2022–OCTOBER 2025 331
TABLE 412 PAUL HARTMANN AG: COMPANY OVERVIEW 332
TABLE 413 PAUL HARTMANN AG: PRODUCTS OFFERED 333
TABLE 414 PAUL HARTMANN AG: DEALS, JANUARY 2022– OCTOBER 2025 334
TABLE 415 WINNER MEDICAL CO., LTD.: COMPANY OVERVIEW 335
TABLE 416 WINNER MEDICAL CO., LTD.: PRODUCTS OFFERED 337
TABLE 417 WINNER MEDICAL: DEALS, JANUARY 2022– OCTOBER 2025 337
TABLE 418 STERIS: COMPANY OVERVIEW 339
TABLE 419 STERIS: PRODUCTS OFFERED 340
TABLE 420 ALPHAPROTECH: COMPANY OVERVIEW 341
TABLE 421 ALPHAPROTECH: PRODUCTS OFFERED 342
TABLE 422 HENRY SCHEIN: COMPANY OVERVIEW 343
TABLE 423 HENRY SCHEIN: PRODUCTS OFFERED 344
TABLE 424 B. BRAUN SE: COMPANY OVERVIEW 345
TABLE 425 B. BRAUN SE: PRODUCTS OFFERED 346
TABLE 426 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 347
TABLE 427 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 348
TABLE 428 LOHMANN & RAUSCHER GMBH & CO. KG: COMPANY OVERVIEW 349
TABLE 429 STANDARD TEXTILE CO., INC.: COMPANY OVERVIEW 350
TABLE 430 PLURITEX S.R.L.: COMPANY OVERVIEW 351
TABLE 431 MEDICA EUROPE BV: COMPANY OVERVIEW 352
TABLE 432 AMARYLLIS HEALTHCARE PVT. LTD.: COMPANY OVERVIEW 353
TABLE 433 STERIMED GROUP: COMPANY OVERVIEW 354
TABLE 434 GPC MEDICAL: COMPANY OVERVIEW 355
TABLE 435 ALLESET: COMPANY OVERVIEW 356
TABLE 436 BOEN HEALTHCARE CO., LTD.: COMPANY OVERVIEW 357
TABLE 437 PRIONTEX: COMPANY OVERVIEW 358
TABLE 438 EURONDA SPA: COMPANY OVERVIEW 359
TABLE 439 TIDI PRODUCTS, LLC.: COMPANY OVERVIEW 360
TABLE 440 SURGICAL GOWNS AND DRAPES MARKET: RESEARCH ASSUMPTIONS 370
TABLE 441 SURGICAL GOWNS AND DRAPES MARKET: RISK ASSESSMENT 371
LIST OF FIGURES
FIGURE 1 SURGICAL GOWNS AND DRAPES MARKET COVERED
AND REGIONAL SEGMENTATION 36
FIGURE 2 KEY INSIGHTS AND MARKET HIGHLIGHTS 40
FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN SURGICAL
GOWNS AND DRAPES MARKET, 2022–2025 41
FIGURE 4 DISRUPTIVE TRENDS IMPACTING GROWTH OF SURGICAL GOWNS
AND DRAPES MARKET 41
FIGURE 5 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN
SURGICAL GOWNS AND DRAPES MARKET, 2024 42
FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 43
FIGURE 7 GROWING PREVALENCE OF HOSPITAL-ACQUIRED INFECTIONS TO DRIVE MARKET 44
FIGURE 8 SURGICAL DRAPE SEGMENT EXPECTED TO DOMINATE MARKET DURING FORECAST PERIOD 45
FIGURE 9 NON-WOVEN MATERIALS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 45
FIGURE 10 STERILE PRODUCTS SEGMENT TO ACCOUNT FOR LARGER SHARE DURING FORECAST PERIOD 46
FIGURE 11 GENERAL SURGERY SEGMENT TO HAVE LARGEST SHARE
DURING FORECAST PERIOD 46
FIGURE 12 HOSPITALS SEGMENT TO COMMAND LARGEST SHARE DURING FORECAST PERIOD 47
FIGURE 13 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 47
FIGURE 14 SURGICAL GOWNS AND DRAPES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 48
FIGURE 15 SURGICAL GOWNS AND DRAPES MARKET: PORTER’S FIVE FORCES ANALYSIS 59
FIGURE 16 SURGICAL GOWNS AND DRAPES MARKET: SUPPLY CHAIN ANALYSIS 65
FIGURE 17 SURGICAL GOWNS AND DRAPES MARKET: VALUE CHAIN ANALYSIS 66
FIGURE 18 SURGICAL GOWNS AND DRAPES MARKET: ECOSYSTEM ANALYSIS 67
FIGURE 19 SURGICAL GOWNS AND DRAPES MARKET: NEW REVENUE POCKETS FOR PLAYERS 72
FIGURE 20 SURGICAL GOWNS AND DRAPES MARKET: INVESTMENT AND FUNDING SCENARIO 73
FIGURE 21 PATENT ANALYSIS FOR SURGICAL GOWNS AND DRAPES,
JANUARY 2015–DECEMBER 2024 84
FIGURE 22 MARKET POTENTIAL OF AI IN SURGICAL GOWNS AND DRAPES MARKET 87
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT TYPE 94
FIGURE 24 KEY BUYING CRITERIA, BY PRODUCT TYPE 95
FIGURE 25 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET SNAPSHOT 206
FIGURE 26 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET SNAPSHOT 246
FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS, 2022–2024 (USD MILLION) 291
FIGURE 28 GLOBAL MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 292
FIGURE 29 US MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 293
FIGURE 30 BRAND/PRODUCT COMPARISON 295
FIGURE 31 SURGICAL GOWNS AND DRAPES MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 297
FIGURE 32 SURGICAL GOWNS AND DRAPES MARKET: COMPANY FOOTPRINT 298
FIGURE 33 SURGICAL GOWNS AND DRAPES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 304
FIGURE 34 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND FIVE-YEAR STOCK
BETA OF KEY VENDORS 307
FIGURE 35 EV/EBITDA OF KEY VENDORS 307
FIGURE 36 CARDINAL HEALTH: COMPANY SNAPSHOT (2024) 312
FIGURE 37 OWENS & MINOR: COMPANY SNAPSHOT (2024) 320
FIGURE 38 MCKESSON CORPORATION: COMPANY SNAPSHOT (2024) 323
FIGURE 39 MÖLNLYCKE AB: COMPANY SNAPSHOT (2024) 327
FIGURE 40 SOLVENTUM: COMPANY SNAPSHOT (2024) 330
FIGURE 41 PAUL HARTMANN AG: COMPANY SNAPSHOT (2024) 333
FIGURE 42 WINNER MEDICAL CO., LTD.: COMPANY SNAPSHOT (2023) 336
FIGURE 43 STERIS: COMPANY SNAPSHOT (2024) 340
FIGURE 44 ALPHAPROTECH: COMPANY SNAPSHOT (2024) 341
FIGURE 45 HENRY SCHEIN: COMPANY SNAPSHOT (2024) 344
FIGURE 46 B. BRAUN SE: COMPANY SNAPSHOT (2024) 346
FIGURE 47 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2024) 348
FIGURE 48 RESEARCH DESIGN 361
FIGURE 49 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 365
FIGURE 50 TOP-DOWN APPROACH 368
FIGURE 51 DATA TRIANGULATION 369
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11
- 鉄道試験市場規模、シェア、動向、2032年までの世界予測 2025-12-10